Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Exp Toxicol ; 37(9): 991-1004, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29271245

RESUMO

A total of 66 male Wistar rats were used and six groups (control: 10 animals and experimental: 12 animals) were formed. While a separate control group was established for each study period, mad honey application to the animals in the experimental group was carried out with a single dose (12.5 g kg-1 body weight (b.w.); acute stage), at a dose of 7.5 g kg-1 b.w. for 21 days (subacute stage), and at a dose of 5 g kg-1 b.w. for 60 days (chronic stage). Tissue and blood oxidative stress markers (malondialdehyde (MDA), nitric oxide (NO), 4-hydroxynonenal (HNE), superoxide dismutase, catalase, glutathione (GSH) peroxidase, and glucose-6-phosphate dehydrogenase), hepatic chemical metabolizing parameters in the liver (cytochrome P450 2E1, nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase, nicotinamide adenine dinucleotide phosphate (NADPH)-cytochrome c reductase (CYTC), GSH S-transferase (GST), and GSH), and micronucleus and comet test in some samples were examined. Findings from the study showed that single and repeated doses given over the period increased MDA, NO, and HNE levels while decreasing/increasing tissue and blood antioxidant enzyme activities. From hepatic chemical metabolizing parameters, GST activity increased in the subacute and chronic stages and CYTC activity increased in the acute period, whereas GSH level decreased in the subacute stage. Changes in tail and head intensities were found in most of the comet results. Mad honey caused oxidative stresses for each exposure period and made some significant changes on the comet test in certain periods for some samples obtained. In other words, according to the available research results obtained, careless consumption of mad honey for different medical purposes is not appropriate.


Assuntos
Dano ao DNA , Diterpenos/toxicidade , Mel/toxicidade , Fígado/efeitos dos fármacos , Micronúcleos com Defeito Cromossômico/induzido quimicamente , Estresse Oxidativo , Animais , Antioxidantes/metabolismo , Biomarcadores/sangue , Ensaio Cometa , Fígado/enzimologia , Fígado/patologia , Masculino , Testes para Micronúcleos , Ratos Wistar , Rhododendron , Fatores de Tempo
2.
Drug Res (Stuttg) ; 65(4): 219-22, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24992496

RESUMO

In this study*, it was aimed to observe, genotoxic effects of antituberculosis drugs and combinations on rats. Animals were treated with 31.5 mg/kg isoniazid (INH), 54 mg/kg rifampicin (RIF), 189 mg/kg pyrazinamide (PYR), 100 mg/kg etham-butol(ETA), INH+RIF+PYR (MIX1) and INH+RIF+PYR+ETA (MIX2) mixtures applied via gavage for 90 days. At the end of the study, blood, liver and kidney samples were taken and evaluated by Comet and Micronucleus techniques. Compared to control group, head intensity decreased, tail intensity and tail migration increased on experiment groups in blood samples. Head intensity of PYR and mixture groups decreased, tail intensity of PYR and mixture groups increased and tail migration of PYR, ETA and mixture groups increased in liver samples. Head intensity decreased and tail intensity increased of INH, RIF, ETA and MIX1 group; tail migration increased of MIX1 group in kidney samples. Compared to control group, micronucleus rate of ETA, RIF and MIX 2 groups increased in experiment groups. In conclusion antituberculosis drugs and their mixtures applied for 90 days causes to double strand break of DNA damage at different degrees in blood, kidney and liver cells in rats.


Assuntos
Antituberculosos/farmacologia , Dano ao DNA/efeitos dos fármacos , Etambutol/farmacologia , Isoniazida/farmacologia , Pirazinamida/farmacologia , Rifampina/farmacologia , Animais , Antituberculosos/sangue , Antituberculosos/farmacocinética , Combinação de Medicamentos , Etambutol/sangue , Etambutol/farmacocinética , Isoniazida/sangue , Isoniazida/farmacocinética , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Pirazinamida/sangue , Pirazinamida/farmacocinética , Ratos , Rifampina/sangue , Rifampina/farmacocinética
3.
Pharmazie ; 60(12): 892-6, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16398263

RESUMO

A comparison of two wavelet approaches, Daubechies and reverse Biorthogonal, is described for the quantitative resolution of a binary mixture of diminazene aceturate (DIMA) and phenazone (PHE) in veterinary granules for injection without any chemical separation. These two approaches were specified as db4 (a = 180) and rbior3.7 (a = 125) respectively, after testing the signal analysis parameters for the overlapping absorption spectra and ratio spectra. In the first step db4 (a = 180) was applied to the original absorbance data vector of DIMA and PHE. In the second step rbio3.7 (a = 125) was applied to the ratio spectra data vectors of DIMA using the divisor PHE. The same approach was also subjected to the ratio spectra of PHE using the divisor DIMA. The db4 (a = 180) and rbior3.7 (a = 125) calibration graphs were constructed using the transformation values obtained in the wavelet domain. In the method validation, the wavelet calibration functions were tested using synthetic mixtures and the standard addition technique. The simultaneous quantitative analysis of DIMA and PHE in the commercial veterinary preparation was achieved by the elaborated methods. The assay results were compared with each other and good agreement was observed.


Assuntos
Anti-Inflamatórios não Esteroides/análise , Antiprotozoários/análise , Antipirina/análise , Diminazena/análogos & derivados , Algoritmos , Anti-Inflamatórios não Esteroides/administração & dosagem , Antiprotozoários/administração & dosagem , Antipirina/administração & dosagem , Química Farmacêutica , Diminazena/administração & dosagem , Diminazena/análise , Injeções , Soluções Farmacêuticas/análise , Pós , Padrões de Referência , Reprodutibilidade dos Testes , Espectrofotometria Ultravioleta , Drogas Veterinárias
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...